Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Tilray Brands, Inc. (TLRY) Cash Flow Statement

Tilray Brands, Inc. (TLRY) generated -$84.3M of operating cash flow over the twelve months to 2026-08-31, spent $17.8M on capital expenditure and had free cash flow of -$102.1M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-08-31 · read by EquiReason

TLRYTilray Brands, Inc.Follow TLRY — free
Drug Manufacturers - Specialty & Generic · Healthcare
—
Price chart with a free account
Market cap
415.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
6 Jan, in 74 days
LineFY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
May 21
FY2022
May 22
FY2023
May 23
FY2024
May 24
FY2025
May 25
FY2026
May 26
TTM
Aug 26
Trend
Operating cash flow-0.05-0.26-0.13-0.04-0.180.01-0.03-0.09-0.07-0.08
Capital expenditure0.050.070.040.040.030.020.030.030.03-0.02
Free cash flow-0.10-0.33-0.17-0.08-0.21-0.01-0.06-0.13-0.10-0.10
Stock-based compensation0.020.030.030.020.040.040.030.020.05—

USD billions · SEC XBRL

Tilray Brands, Inc. — questions

What is Tilray Brands, Inc.'s operating cash flow?
-$84.3M over the twelve months to 2026-08-31.
How much does Tilray Brands, Inc. spend on capital expenditure?
$17.8M over the twelve months to 2026-08-31.
What is Tilray Brands, Inc.'s free cash flow?
-$102.1M over the twelve months to 2026-08-31: operating cash flow minus capital expenditure.

Every figure on this page comes from Tilray Brands, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.